Key Quantitative Figures

  • Total Rights Issue Size: Proposed 1,25,70,000 Equity Shares of ₹10 each at ₹19 per share (including premium of ₹9) aggregating to ₹23.88 crore
  • Amount Actually Called: ₹5 per share called during Q2 FY2026 aggregating to ₹6.29 crore
  • Uncalled Amount: ₹14 per share (₹17.59 crore) remaining uncalled as of March 31, 2026
  • Issue Expenses: ₹0.50 crore estimated as per prospectus
  • Net Proceeds for Utilization: ₹23.38 crore proposed, ₹6.04 crore actually received

Utilization Breakdown (as of March 31, 2026)

1. Working Capital Requirements: ₹15.00 crore proposed, ₹3.03 crore actually utilized

2. Repayment of Loan to Laxmimanak Finance Pvt. Ltd.: ₹2.75 crore proposed, ₹2.75 crore fully utilized

3. General Corporate Purpose: ₹5.63 crore proposed, ₹0.26 crore utilized

Dates and Timeline

  • Record Date: May 29, 2025
  • Issue Period: June 4, 2025 to July 3, 2025
  • Letter of Offer Date: May 27, 2025
  • Monitoring Agency Agreement Date: May 29, 2025
  • Report Period: Quarter ended March 31, 2026
  • Certification Dates: CA Certificate dated May 13, 2026; Management Declaration dated May 12, 2026

Parties Involved

  • Issuer: Aplab Limited
  • Promoter: Ms. Amrita Prabhakar Deodhar
  • Monitoring Agency: Infomerics Valuation and Rating Limited (Gaurav Jain, Director - Ratings)
  • Statutory Auditors: R. Bhargava & Associates, Chartered Accountants
  • Lender: Laxmimanak Finance Pvt. Ltd. (loan of ₹2.75 crore outstanding as of December 31, 2024)
  • Stock Exchange: BSE Limited (Scrip Code: Fully Paid - 517096, Partly Paid - 890217)

Key Findings from Monitoring Report

  • No deviations from objects of the issue
  • No material deviation (defined as >10% variance from projected amounts)
  • No change in means of finance for disclosed objects
  • All government/statutory approvals obtained
  • No favorable/unfavorable events affecting object viability
  • No utilizations made during Q4 FY2026
  • No delay in implementation reported
  • No unutilized funds invested in any instruments

Financial Impact

Total proceeds of ₹6.29 crore received were fully utilized in Q2 FY2026 itself. No funds remained unutilized at end of FY2026. The company had scheduled to utilize entire proceeds earmarked for objects by end of FY2026, but only partial funds were called.

Working Capital Projections

Company expects Trade Payable Days to reduce from 101 (Dec 31, 2024) to 76 in FY26, and Trade Receivable Days to decline from 142 to 95 over same period, supported by improved liquidity from proposed working capital funding.

General Corporate Purpose Scope

Includes funding growth opportunities, strategic initiatives, ordinary business expenses, working capital requirements, brand building, marketing expenses, and repayment of current liabilities, not exceeding 25% of issue proceeds.

#Tags: #AplabLimited #RightsIssue #SEBICDR #FundUtilization #RegulatoryCompliance #Neutral